NEUROPACE, INC. Operating Lease Cost
NEUROPACE, INC. (NPCE) reported Operating Lease Cost of $700.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-11
- NEUROPACE, INC. operating lease, cost for the quarter ending 2026-06-30 was $700.00K, a 0.00% change year-over-year.
- NEUROPACE, INC. operating lease, cost for the quarter ending 2026-03-31 was $700.00K, a 0.00% change year-over-year.
- NEUROPACE, INC. operating lease, cost for the quarter ending 2025-12-31 was $700.00K, a 0.00% change year-over-year.
- NEUROPACE, INC. operating lease, cost for the quarter ending 2025-09-30 was $700.00K, a 0.00% change year-over-year.
- NEUROPACE, INC. operating lease, cost for fiscal 2025 was $2.80M, a 0.00% change from fiscal 2024.
- NEUROPACE, INC. operating lease, cost for fiscal 2024 was $2.80M, a 0.00% change from fiscal 2023.
- NEUROPACE, INC. operating lease, cost for fiscal 2023 was $2.80M, a 0.00% change from fiscal 2022.
- NEUROPACE, INC. operating lease, cost for fiscal 2022 was $2.80M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $700.00K 10-Q · filed 2026-08-11 | $1.40M 10-Q · filed 2026-08-11 | $2.10M derived: sum of 3 quarters · filed 2026-08-11 | $2.80M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $700.00K 10-Q · filed 2026-05-12 | $1.40M derived: sum of 2 quarters · filed 2026-05-12 | $2.10M derived: sum of 3 quarters · filed 2026-05-12 | $2.80M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.40M derived: sum of 2 quarters · filed 2026-03-03 | $2.10M derived: sum of 3 quarters · filed 2026-08-11 | $2.80M 10-K · filed 2026-03-03 | |
| 2025-09-30 | $700.00K 10-Q · filed 2025-11-04 | $1.40M derived: sum of 2 quarters · filed 2026-08-11 | $2.10M 10-Q · filed 2025-11-04 | $2.80M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $700.00K 10-Q · filed 2026-08-11 | $1.40M 10-Q · filed 2026-08-11 | $2.10M derived: sum of 3 quarters · filed 2026-08-11 | $2.80M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $700.00K 10-Q · filed 2026-05-12 | $1.40M derived: sum of 2 quarters · filed 2026-05-12 | $2.10M derived: sum of 3 quarters · filed 2026-05-12 | $2.80M derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.40M derived: sum of 2 quarters · filed 2026-03-03 | $2.10M derived: sum of 3 quarters · filed 2026-03-03 | $2.80M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $700.00K 10-Q · filed 2025-11-04 | $1.40M derived: sum of 2 quarters · filed 2025-11-04 | $2.10M 10-Q · filed 2025-11-04 | $2.80M derived: sum of 4 quarters · filed 2025-11-04 | |
| 2024-06-30 | $700.00K 10-Q · filed 2025-08-12 | $1.40M 10-Q · filed 2025-08-12 | $2.10M derived: sum of 3 quarters · filed 2025-08-12 | $2.80M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $700.00K 10-Q · filed 2025-05-13 | $1.40M derived: sum of 2 quarters · filed 2025-05-13 | $2.10M derived: sum of 3 quarters · filed 2025-05-13 | $2.80M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $1.40M derived: sum of 2 quarters · filed 2025-03-04 | $2.10M derived: sum of 3 quarters · filed 2025-03-04 | $2.80M 10-K · filed 2025-03-04 | $2.70M 10-K · filed 2024-03-05 |
| 2023-09-30 | $700.00K 10-Q · filed 2024-11-12 | $1.40M derived: sum of 2 quarters · filed 2024-11-12 | $2.10M 10-Q · filed 2024-11-12 | $2.90M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $700.00K 10-Q · filed 2024-08-13 | $1.40M 10-Q · filed 2024-08-13 | $2.20M derived: sum of 3 quarters · filed 2024-08-13 | $2.90M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $700.00K 10-Q · filed 2024-05-08 | $1.50M derived: sum of 2 quarters · filed 2024-05-08 | $2.20M derived: sum of 3 quarters · filed 2024-05-08 | $2.90M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.50M derived: sum of 2 quarters · filed 2024-03-05 | $2.20M derived: sum of 3 quarters · filed 2024-03-05 | $2.80M 10-K · filed 2024-03-05 | $2.70M 10-K · filed 2023-03-02 |
| 2022-09-30 | $700.00K 10-Q · filed 2023-11-06 | $1.40M derived: sum of 2 quarters · filed 2023-11-06 | $2.00M 10-Q · filed 2023-11-06 | ||
| 2022-06-30 | $700.00K 10-Q · filed 2023-08-08 | $1.30M 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | $700.00K 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |